查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954692

牙科生物再生材料市場規模、佔有率、成長及全球產業分析：依產品類型、形態、最終用戶和地區劃分的洞察與預測（2026-2034年）

Dental Orthobiologics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 請詢問到貨日

價格

牙科生物再生材料市場成長驅動因素

全球牙科生物再生材料市場規模在2025年達到 10.19億美元，預計從2026年的10.4806億美元成長至2034年的16.1259億美元，在預測期（2026-2034年）內年複合成長率為 5.50%。2025年，北美市場佔據主導地位，市場佔有率高達48.73%，這主要得益於對牙科植體的高需求和強勁的產品創新。

牙科生物再生材料包括天然和合成材料，目的是促進牙科治療中骨骼、軟骨和軟組織的再生。這些產品包括同種異體移植材料、合成骨移植替代物、脫礦骨基質、細胞同種異體移植材料、骨生長因子以及其他用於牙科種植、牙周再生和顎骨重建等手術的生物製劑。

市場動態

由於無牙症、牙周病和齒槽骨吸收等牙科疾病的增加，市場擴張。這些疾病通常需要進行骨移植和再生治療，這推動了對生物衍生再生材料的需求。根據世界衛生組織的資料，口腔疾病影響全球數十億人，無牙頜的盛行率顯著上升，尤其是在老齡化社會。

2020年，因新冠疫情導致牙醫診所限制營業，市場收入暫時下降。然而，隨著診所重新開放以及植牙手術和骨移植手術的普及，市場在2021年開始復甦。遠距牙科和數位化治療計劃的日益普及進一步推動了手術量的成長。

主要市場趨勢

影響牙科生物再生材料市場的主要趨勢之一是植牙手術的快速成長。當天然骨量不足時，骨移植替代材料廣泛用於增加顎骨體積並確保植體的穩定性。種植技術的進步增加了手術的複雜性，進一步推動了對先進再生材料的需求。

另一個新興趨勢是合成和3D列印骨移植替代材料的日益普及。這些產品相比傳統移植材料具有許多優勢，例如更高的生物相容性、可預測的再生效果以及成本效益。生物再生材料的創新正為複雜的牙科手術提供更個人化的解決方案。

成長因素

牙骨疾病的日益普遍是推動市場成長的主要因素。牙周病、牙齒脫落和下顎骨萎縮都需要使用生物再生材料進行再生治療。臨床醫師對先進再生解決方案的認識不斷提高，也加速了這些解決方案的普及應用。

此外，合成骨替代材料的廣泛應用也推動了市場成長。這些材料具有優異的骨傳導性能，同時降低了免疫反應和疾病傳播的風險。價格優勢和易得性進一步推動了它們在新興市場的普及應用。

產業參與者之間的策略性收購和聯盟也有助於加強產品組合併拓展全球分銷網路。

限制因子

儘管具有成長潛力，但臨床限制可能會阻礙市場擴張。一些生物來源的再生材料與不良組織反應、骨形成不完全和免疫原性風險有關。與骨形態發生蛋白和異種移植相關的發炎和移植物移位等併發症可能會阻礙其應用。

此外，對機械強度、吸收率和手術時長的擔憂可能會影響臨床醫生的選擇和患者的治療結果，對市場成長構成挑戰。

市場區隔分析

依產品類型

預計到2026年，骨生長因子細分市場將佔據主導地位，市場佔有率達到41.31%，這主要得益於需要高級骨再生技術的牙科植牙手術數量的增加。由於其生物相容性、低製造成本和不斷擴大的出口合作關係，合成骨移植替代物預計將以更高的年複合成長率成長。

依劑型

預計2026年，糊劑型骨生長因子市場佔有率將達到45.35%，主要得益於強大的研發投入和糊劑型骨生長因子的廣泛應用。顆粒劑型骨生長因子市場佔有率預計將以更高的年複合成長率成長，這主要歸功於其優異的成骨細胞附著能力和新產品上市數量的增加。

依最終使用者

預計到2026年，私人診所市場佔有率將達到60.49%，這主要得益於數量眾多的獨立牙科診所和患者對私人診所骨生長因子的高偏好。由於整合趨勢和手術量增加，預計牙科服務機構/集團診所將經歷更快的成長。

區域洞察

到2025年，北美市場規模達到 4.8737億美元，憑藉其先進的醫療保健基礎設施和頻繁的新產品發布，將保持領先地位。

歐洲市場規模位居第二，這得益於 Institut Straumann AG 和 Geistlich Pharma AG 等領導企業的支持。

由於牙科疾病盛行率上升、醫療保健支出增加以及日本、中國和印度等國家對先進產品的日益普及，預計亞太地區將以最高的年複合成長率成長。

由於人們健康意識的提高和醫療保健投資的增加，預計拉丁美洲以及中東和非洲市場將保持穩定成長。

主要公司

主要公司包括 ZimVie Inc.、Institut Straumann AG、Envista、Dentsply Sirona、Henry Schein、Medtronic、BioHorizons、NovaBone 和 Geistlich Pharma AG。策略性收購、產品發布和地理擴張在維持競爭優勢方面發揮核心作用。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 主要國家和地區牙科疾病盛行率（2025年）
  • 主要產業趨勢：併購、合作等
  • 主要公司新產品發布
  • 新冠疫情對市場的影響

第5章 全球牙科生物再生材料市場分析、洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品類型劃分
    • 同種異體移植
    • 骨生長因子
    • 合成骨移植替代物
    • 去礦物質骨基質
    • 細胞同種異體移植
    • 其他
  • 市場分析、洞察與預測：依類型劃分
    • 糊膏
    • 顆粒
    • 油灰
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 私人診所
    • 牙科服務機構/集團診所
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北部美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美牙科生物再生材料市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲牙科生物再生材料市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 北歐國家
    • 歐洲其他地區

第8章 亞太地區牙科市場生物再生材料市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 韓國
    • 亞太其他地區

第9章 拉丁美洲牙科生物再生材料市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第10章 中東與非洲牙科生物材料市場分析、洞察與預測（2021-2034）

  • 依國家/地區
    • GCC國家
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 全球市場佔有率分析（2025）
  • 公司簡介
    • ZimVie Inc.
    • Institut Straumann AG
    • Envista
    • Dentsply Sirona.
    • Henry Schein, Inc.
    • Medtronic
    • BioHorizons
    • NovaBone（Halma）
    • Geistlich Pharma AG
Product Code: FBI110353

Growth Factors of dental orthobiologics Market

The global dental orthobiologics market size was valued at USD 1,000.19 million in 2025 and is projected to grow from USD 1,048.06 million in 2026 to USD 1,612.59 million by 2034, exhibiting a CAGR of 5.50% during the forecast period (2026-2034). North America dominated the market in 2025, accounting for a 48.73% share, driven by high dental implant volumes and strong product innovation.

Dental orthobiologics include natural and synthetic materials designed to promote bone, cartilage, and soft tissue regeneration in dental applications. These products comprise allografts, synthetic bone graft substitutes, demineralized bone matrix, cellular allografts, bone growth factors, and other biologics used in procedures such as dental implants, periodontal regeneration, and jawbone reconstruction.

Market Dynamics

The market is expanding due to the increasing prevalence of dental disorders such as edentulism, periodontal disease, and alveolar bone loss. These conditions frequently require bone grafting and regenerative procedures, thereby driving demand for orthobiologic materials. According to global health reports, oral diseases affect billions of people worldwide, with edentulism showing significant prevalence among aging populations.

The COVID-19 pandemic temporarily reduced market revenues in 2020 as dental clinics restricted services. However, recovery began in 2021 with the reopening of clinics and increased adoption of implant surgeries and bone grafting procedures. The growing use of tele-dentistry and digital treatment planning further supported procedural volumes.

Key Market Trends

A significant trend shaping the dental orthobiologics market is the rapid increase in dental implant procedures. Bone graft substitutes are widely used to enhance jawbone volume and ensure implant stability when natural bone is insufficient. Technological advancements in implantology have increased procedural complexity, further boosting the need for advanced regenerative materials.

Another emerging trend is the growing adoption of synthetic and 3D-printed bone graft substitutes. These products offer improved biocompatibility, predictable regeneration outcomes, and cost efficiency compared to traditional grafts. Innovations in biomaterials are enabling more customized solutions for complex dental surgeries.

Growth Drivers

The rising prevalence of dental bone disorders is a primary growth driver. Periodontal disease, tooth loss, and jawbone atrophy require regenerative procedures supported by orthobiologic materials. Increasing awareness among clinicians about advanced regenerative solutions is also accelerating adoption.

Additionally, the growing use of synthetic bone substitutes is fueling market growth. These materials reduce the risk of immune reactions and disease transmission while offering improved osteoconductive properties. Their affordability and ease of availability further enhance adoption across emerging markets.

Strategic acquisitions and collaborations among industry players are also strengthening product portfolios and expanding global distribution networks.

Restraining Factors

Despite growth potential, clinical limitations may restrict market expansion. Some orthobiologic products are associated with adverse tissue reactions, incomplete bone formation, and immunogenic risks. Complications related to bone morphogenetic proteins and xenografts, such as inflammation or graft displacement, may hinder adoption.

Furthermore, concerns regarding mechanical strength, resorption rates, and long surgical times can affect clinician preference and patient outcomes, posing challenges to market growth.

Market Segmentation Analysis

By Product Type

The bone growth factors segment dominated with a 41.31% share in 2026, driven by rising dental implant procedures that require enhanced bone regeneration. Synthetic bone graft substitutes are expected to grow at a higher CAGR due to their biocompatibility, lower production costs, and increasing export collaborations.

By Form

The paste segment held 45.35% of the market share in 2026, supported by strong R&D focus and widespread use of bone growth factors in paste form. The granules segment is projected to grow at a higher CAGR due to superior osteoblast attachment and increasing product launches.

By End-user

The solo practices segment accounted for 60.49% share in 2026, owing to a large number of independent dental clinics and high patient preference. DSO/group practices are anticipated to grow at a faster rate due to consolidation trends and rising procedural volumes.

Regional Insights

North America generated USD 487.37 million in 2025, maintaining its leadership due to advanced healthcare infrastructure and frequent product launches.

Europe represents the second-largest market, supported by strong players such as Institut Straumann AG and Geistlich Pharma AG.

Asia Pacific is projected to grow at the highest CAGR, driven by rising dental disease prevalence, increasing healthcare spending, and growing penetration of advanced products in Japan, China, and India.

Latin America and the Middle East & Africa are expected to witness steady growth due to rising awareness and healthcare investments.

Key Industry Players

Leading companies include ZimVie Inc., Institut Straumann AG, Envista, Dentsply Sirona, Henry Schein, Medtronic, BioHorizons, NovaBone, and Geistlich Pharma AG. Strategic acquisitions, product launches, and geographic expansions are central to maintaining competitive advantage.

Conclusion

The global dental orthobiologics market is set for steady expansion, increasing from USD 1,000.19 million in 2025 to USD 1,612.59 million by 2034, at a CAGR of 5.50%. Growth is driven by rising dental implant procedures, increasing prevalence of bone disorders, and advancements in synthetic graft technologies. Although clinical limitations pose challenges, continuous innovation, strategic collaborations, and expanding dental care infrastructure are expected to sustain long-term market growth worldwide.

Segmentation By Product Type

  • Allograft
  • Synthetic Bone Graft Substitutes
  • Demineralized Bone Matrix
  • Cellular Allografts
  • Bone Growth Factors
  • Others

By Form

  • Paste
  • Granules
  • Putty
  • Others

By End-user

  • Solo Practices
  • DSO/ Group Practices
  • Others

North America (By Product Type, Form, End-user, Country)

    • U.S.
    • Canada
  • Europe (By Product Type, Form, End-user, Country/ Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, Form, End-user, Country/ Sub-region)
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, Form, End-user, Country/ Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, Form, End-user, Country/ Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Dental Disorders, By Key Countries/ Region, 2025
  • 4.2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
  • 4.3. New Product Launches, By Key Players
  • 4.4. Impact of COVID-19 on the Market

5. Global Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Allograft
    • 5.1.2. Bone Growth Factors
    • 5.1.3. Synthetic Bone Graft Substitute
    • 5.1.4. Demineralized Bone Matrix
    • 5.1.5. Cellular Allografts
    • 5.1.6. Others
  • 5.2. Market Analysis, Insights and Forecast - By Form
    • 5.2.1. Paste
    • 5.2.2. Granules
    • 5.2.3. Putty
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Solo Practices
    • 5.3.2. DSO/Group Practices
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Allograft
    • 6.1.2. Bone Growth Factors
    • 6.1.3. Synthetic Bone Graft Substitute
    • 6.1.4. Demineralized Bone Matrix
    • 6.1.5. Cellular Allografts
    • 6.1.6. Others
  • 6.2. Market Analysis, Insights and Forecast - By Form
    • 6.2.1. Paste
    • 6.2.2. Granules
    • 6.2.3. Putty
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Solo Practices
    • 6.3.2. DSO/Group Practices
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Allograft
    • 7.1.2. Bone Growth Factors
    • 7.1.3. Synthetic Bone Graft Substitute
    • 7.1.4. Demineralized Bone Matrix
    • 7.1.5. Cellular Allografts
    • 7.1.6. Others
  • 7.2. Market Analysis, Insights and Forecast - By Form
    • 7.2.1. Paste
    • 7.2.2. Granules
    • 7.2.3. Putty
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Solo Practices
    • 7.3.2. DSO/Group Practices
    • 7.3.3. Others

8. Market Analysis, Insights and Forecast - By Country/ Sub-Region

  • 8.1.
    • 8.1.1. U.K.
    • 8.1.2. Germany
    • 8.1.3. France
    • 8.1.4. Spain
    • 8.1.5. Italy
    • 8.1.6. Scandinavia
    • 8.1.7. Rest of Europe

9. Asia Pacific Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Allograft
    • 9.1.2. Bone Growth Factors
    • 9.1.3. Synthetic Bone Graft Substitute
    • 9.1.4. Demineralized Bone Matrix
    • 9.1.5. Cellular Allografts
    • 9.1.6. Others
  • 9.2. Market Analysis, Insights and Forecast - By Form
    • 9.2.1. Paste
    • 9.2.2. Granules
    • 9.2.3. Putty
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Solo Practices
    • 9.3.2. DSO/Group Practices
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Australia
    • 9.4.5. Southeast Asia
    • 9.4.6. South Korea
    • 9.4.7. Rest of Asia Pacific

10. Latin America Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Allograft
    • 10.1.2. Bone Growth Factors
    • 10.1.3. Synthetic Bone Graft Substitute
    • 10.1.4. Demineralized Bone Matrix
    • 10.1.5. Cellular Allografts
    • 10.1.6. Others
  • 10.2. Market Analysis, Insights and Forecast - By Form
    • 10.2.1. Paste
    • 10.2.2. Granules
    • 10.2.3. Putty
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Solo Practices
    • 10.3.2. DSO/Group Practices
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. Brazil
    • 10.4.2. Mexico
    • 10.4.3. Rest of Latin America

11. Middle East & Africa Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 11.1. Market Analysis, Insights and Forecast - By Product Type
    • 11.1.1. Allograft
    • 11.1.2. Bone Growth Factors
    • 11.1.3. Synthetic Bone Graft Substitute
    • 11.1.4. Demineralized Bone Matrix
    • 11.1.5. Cellular Allografts
    • 11.1.6. Others
  • 11.2. Market Analysis, Insights and Forecast - By Form
    • 11.2.1. Paste
    • 11.2.2. Granules
    • 11.2.3. Putty
    • 11.2.4. Others
  • 11.3. Market Analysis, Insights and Forecast - By End-user
    • 11.3.1. Solo Practices
    • 11.3.2. DSO/Group Practices
    • 11.3.3. Others
  • 11.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 11.4.1. GCC
    • 11.4.2. South Africa
    • 11.4.3. Rest of Middle East & Africa

12. Competitive Analysis

  • 12.1. Global Market Share Analysis (2025)
  • 12.2. Company Profiles
    • 12.2.1. ZimVie Inc.
      • 12.2.1.1. Overview
      • 12.2.1.2. Products & services
      • 12.2.1.3. SWOT Analysis
      • 12.2.1.4. Recent Developments
      • 12.2.1.5. Strategies
      • 12.2.1.6. Financials (Based on Availability)
    • 12.2.2. Institut Straumann AG
      • 12.2.2.1. Overview
      • 12.2.2.2. Products & services
      • 12.2.2.3. SWOT Analysis
      • 12.2.2.4. Recent Developments
      • 12.2.2.5. Strategies
      • 12.2.2.6. Financials (Based on Availability)
    • 12.2.3. Envista
      • 12.2.3.1. Overview
      • 12.2.3.2. Products & services
      • 12.2.3.3. SWOT Analysis
      • 12.2.3.4. Recent Developments
      • 12.2.3.5. Strategies
      • 12.2.3.6. Financials (Based on Availability)
    • 12.2.4. Dentsply Sirona.
      • 12.2.4.1. Overview
      • 12.2.4.2. Products & services
      • 12.2.4.3. SWOT Analysis
      • 12.2.4.4. Recent Developments
      • 12.2.4.5. Strategies
      • 12.2.4.6. Financials (Based on Availability)
    • 12.2.5. Henry Schein, Inc.
      • 12.2.5.1. Overview
      • 12.2.5.2. Products & services
      • 12.2.5.3. SWOT Analysis
      • 12.2.5.4. Recent Developments
      • 12.2.5.5. Strategies
      • 12.2.5.6. Financials (Based on Availability)
    • 12.2.6. Medtronic
      • 12.2.6.1. Overview
      • 12.2.6.2. Products & services
      • 12.2.6.3. SWOT Analysis
      • 12.2.6.4. Recent Developments
      • 12.2.6.5. Strategies
      • 12.2.6.6. Financials (Based on Availability)
    • 12.2.7. BioHorizons
      • 12.2.7.1. Overview
      • 12.2.7.2. Products & services
      • 12.2.7.3. SWOT Analysis
      • 12.2.7.4. Recent Developments
      • 12.2.7.5. Strategies
      • 12.2.7.6. Financials (Based on Availability)
    • 12.2.8. NovaBone (Halma)
      • 12.2.8.1. Overview
      • 12.2.8.2. Products & services
      • 12.2.8.3. SWOT Analysis
      • 12.2.8.4. Recent Developments
      • 12.2.8.5. Strategies
      • 12.2.8.6. Financials (Based on Availability)
    • 12.2.9. Geistlich Pharma AG
      • 12.2.9.1. Overview
      • 12.2.9.2. Products & services
      • 12.2.9.3. SWOT Analysis
      • 12.2.9.4. Recent Developments
      • 12.2.9.5. Strategies
      • 12.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 2: Global Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 3: Global Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 4: Global Dental Orthobiologics Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 5: North America Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 6: North America Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 7: North America Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 8: North America Dental Orthobiologics Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 9: Europe Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 10: Europe Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 11: Europe Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 12: Europe Dental Orthobiologics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 14: Asia Pacific Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 15: Asia Pacific Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 16: Asia Pacific Dental Orthobiologics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 18: Latin America Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 19: Latin America Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 20: Latin America Dental Orthobiologics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 22: Middle East & Africa Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 23: Middle East & Africa Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 24: Middle East & Africa Dental Orthobiologics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Dental Orthobiologics Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Dental Orthobiologics Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Dental Orthobiologics Market Value Share (%), by Form, 2025 & 2034
  • Figure 4: Global Dental Orthobiologics Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Dental Orthobiologics Market Value (USD million), by Region, 2025 & 2034
  • Figure 6: North America Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 7: North America Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 8: North America Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 9: North America Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 10: North America Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 11: North America Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 12: North America Dental Orthobiologics Market Value (USD million), By Country, 2025 & 2034
  • Figure 13: North America Dental Orthobiologics Market Value Share (%), By Country, 2025
  • Figure 14: Europe Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 15: Europe Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 16: Europe Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 17: Europe Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 18: Europe Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 19: Europe Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Dental Orthobiologics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Dental Orthobiologics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 23: Asia Pacific Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 24: Asia Pacific Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 25: Asia Pacific Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 26: Asia Pacific Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Dental Orthobiologics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Dental Orthobiologics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 31: Latin America Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 32: Latin America Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 33: Latin America Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 34: Latin America Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 35: Latin America Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Dental Orthobiologics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Dental Orthobiologics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 39: Middle East & Africa Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 40: Middle East & Africa Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 41: Middle East & Africa Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 42: Middle East & Africa Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa Dental Orthobiologics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Dental Orthobiologics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Dental Orthobiologics Market Share (%), By Company, 2025